Literature DB >> 32606191

A Monocentric Retrospective Observational Study of Comorbidities in Patients Affected by Autoimmune Bullous Diseases.

Martina Ferranti1, Giulia Gobbo1, Giulia Tadiotto Cicogna1, Mauro Alaibac2.   

Abstract

BACKGROUND/AIM: Autoimmune bullous diseases (AIBDs) of the skin and mucosae include a heterogeneous group of chronic diseases, which could be associated with various comorbidities. The purpose of this study was to evaluate the comorbidity profiles of patients affected by AIBDs, who referred to the Dermatological Clinic of Padua from December 2015 to June 2018. PATIENTS AND METHODS: A monocentric retrospective observational study was conducted on 157 patients with diagnosis of AIBDs. Patients' comorbidities were investigated during the periodic visits of follow-up and through the analysis of computerized medical records.
RESULTS: Among the 157 patients, 40 (25.5%) were diagnosed with PV, 15 (9.6%) with PF, and 102 (64.9%) with BP. Nine different comorbidities were observed, but only two of these were statistically significantly associated with BP: type 2 diabetes (p=0.0142) and neuropsychiatric disorders (p=0.015).
CONCLUSION: BP is statistically significantly associated with type 2 diabetes mellitus and neuropsychiatric diseases. The correlation with neuropsychiatric pathologies is interesting for the possible bidirectional role in their etiology. The association with type 2 diabetes mellitus could suggest more caution in the administration of systemic corticosteroids, especially in elderly patients. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  AIBDs; autoimmune bullous diseases; bullous pemphigoid; comorbidities; neuropsychiatric diseases; pemphigus; type 2 diabetes mellitus

Mesh:

Year:  2020        PMID: 32606191      PMCID: PMC7439873          DOI: 10.21873/invivo.12016

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  44 in total

1.  The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study.

Authors:  Kathy Taghipour; Ching-Chi Chi; Angela Vincent; Richard W Groves; Vanessa Venning; Fenella Wojnarowska
Journal:  Arch Dermatol       Date:  2010-11

2.  Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.

Authors:  Noa Kremer; Tal Zeeli; Eli Sprecher; Shamir Geller
Journal:  Int J Dermatol       Date:  2017-08-30       Impact factor: 2.736

3.  Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Lancet       Date:  2011-11-25       Impact factor: 79.321

4.  Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study.

Authors:  A Langer-Gould; K B Albers; S K Van Den Eeden; L M Nelson
Journal:  Mult Scler       Date:  2010-05-12       Impact factor: 6.312

Review 5.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

6.  A population-based study of the association between bullous pemphigoid and neurologic disorders.

Authors:  Katherine E Brick; Chad H Weaver; Rodolfo Savica; Christine M Lohse; Mark R Pittelkow; Bradley F Boeve; Lawrence E Gibson; Michael J Camilleri; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-08-29       Impact factor: 11.527

7.  Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.

Authors:  J Béné; G Moulis; I Bennani; M Auffret; P Coupe; S Babai; D Hillaire-Buys; J Micallef; S Gautier
Journal:  Br J Dermatol       Date:  2016-07-19       Impact factor: 9.302

8.  Systemic lupus erythematosus and thrombosis.

Authors:  Mario Bazzan; Antonella Vaccarino; Fabio Marletto
Journal:  Thromb J       Date:  2015-04-23

9.  Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.

Authors:  Takaaki Murakami; Daisuke Yabe; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2019-05-14       Impact factor: 4.232

Review 10.  Collagen XVII: a shared antigen in neurodermatological interactions?

Authors:  Allan Seppänen
Journal:  Clin Dev Immunol       Date:  2013-06-26
View more
  2 in total

1.  Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China.

Authors:  Bingjie Zhang; Xinyi Chen; Yangchun Liu; Fangyuan Chen; Nan Yang; Li Li
Journal:  Ther Adv Chronic Dis       Date:  2022-10-15       Impact factor: 4.970

2.  Comorbidities in Patients with Autoimmune Bullous Disorders: Hospital-Based Registry Study.

Authors:  Verónica Sánchez-García; Lorena Pérez-Alcaraz; Isabel Belinchón-Romero; Jose-Manuel Ramos-Rincón
Journal:  Life (Basel)       Date:  2022-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.